Toxicity of Oligodeoxynucleotide Therapeutic Agents
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Inhibition of Coagulation by a Phosphorothioate OligonucleotideAntisense and Nucleic Acid Drug Development, 1997
- Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 MiceAntisense and Nucleic Acid Drug Development, 1997
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotideInternational Journal of Immunopharmacology, 1996
- Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosisBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Renal uptake of an 18-mer phosphorothioate oligonucleotideKidney International, 1995
- Antisense inhibition ofEngrailed genes in mouse embryos reveals roles for these genes in craniofacial and neural tube developmentTeratology, 1995
- Antisense targeting of Engrailed‐1 causes abnormal axis formation in mouse embryosTeratology, 1995
- Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapyKidney International, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995